NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Oklo and Switch partner on nuclear

January 6, 2025, 9:31AMNuclear News

Advanced nuclear company Oklo and data center developer Switch closed out 2024 by announcing a new partnership to deploy 12 GW of advanced nuclear power under a master power agreement....

Insights from the NRC’s Annie Caputo

December 16, 2024, 12:00PMNuclear News

In a one-on-one interview with the American Nuclear Society’s chief executive officer/executive director Craig Piercy, Nuclear Regulatory Commission commissioner Annie Caputo shared her...